Benlysta Market Growth Trajectory and Insights Through 2030

agregó una foto Health

2025-01-11 12:54:29 - Translate -

Introduction to Benlysta (Belimumab)Benlysta (belimumab), developed by GlaxoSmithKline (GSK), is a monoclonal antibody designed to specifically target and inhibit B-lymphocyte stimulator (BLyS), a protein essential for B cell survival. Approved for the treatment of systemic lupus erythematosus (SLE) and lupus nephritis, Benlysta has become a significant milestone in managing autoimmune...

0 Commentarios 0 Acciones 91 Views 0 Vista previa